Pericardial Patches Market - Top Companies and Manufacturers

  • Report ID: 4589
  • Published Date: Nov 29, 2024
  • Report Format: PDF, PPT

Global Pericardial Patches Market

  1. Introduction
    1. Study Objective
    2. Scope of the report
    3. Market Taxonomy
  2. Study Assumptions and Abbreviations
    1. Research Methodology
    2. Secondary Research
    3. Primary Research
    4. SPSS Approach
    5. Data Triangulation
  3. Executive Summary
  4. Global Industry Overview Market Overview
    1. Market Overview
    2. Regional Synopsis
    3. Industry Supply Chain Analysis
    4. DROTs
    5. Government Regulation: How they would Aid the Business?
    6. Competitive Landscape
      1. ARTIVION, INC
      2. Abbott Laboratories
      3. Baxter International.
      4. Collagen Solutions (US) LLC
      5. Edwards Lifesciences Corporation
      6. FOC Medical S.A.
      7. Labcor Laboratórios Ltda
      8. LeMaitre Vascular, Inc.
      9. Visionary Medtech Solutions Pvt. Ltd.
      10. W. L. Gore & Associates, Inc.
    7. Ongoing Technological Advancements
    8. Price Benchmarking
    9. SWOT Analysis
    10. Unique Selling Proposition (USP)
    11. Startup Overview
    12. End user in Pericardial Patches
    13. Root Cause Analysis
    14. Business Expansion in Different Region
    15. Porter’s Five Forces
    16. Pericardial Patches Utilization in Medical Devices Developed by iVascular
    17. Key Players in the Market
    18. Recent Development Analysis
    19. Industry Risk Assessment
  5. Gobal Outlook and Projections
    1. Global Overview
      1. Market Value (USD Million), Current and Future Projections, 2024-2037
      2. Increment $ Opportunity Assessment, 2024-2037
      3. Year-on-Year Growth Forecast (%)
    2. Global Segmentation (USD Million), 2024-2037, By
      1. Type, Value (USD Million)
        1. Synthetic Pericardial Patches
        2. Biological Pericardial Patches
          1. Autologous
          2. Xenograft
      2. Source, Value (USD Million)
        1. Bovine
        2. Porcine
        3. Equine
        4. Others
      3. Application, Value (USD Million)
        1. Cardiovascular Surgery
        2. Heart Valve Repair
        3. Congenital Heart Defects
        4. Dental Surgery
        5. Others
      4. End user, Value (USD Million)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Center
        4. Research and Academic Institutes
      5. Regional Synopsis (USD Million), 2024-2037
        1. North America, Value (USD Million)
        2. Europe, Value (USD Million)
        3. Asia Pacific, Value (USD Million)
        4. Latin America, Value (USD Million)
        5. Middle East and Africa, Value (USD Million)
  6. North America Market
    1. Overview
      1. Market Value (USD Million), Current and Future Projections, 2024-2037
      2. Increment $ Opportunity Assessment, 2024-2037
      3. Year-on-Year Growth Forecast (%)
    2. Segmentation (USD Million), 2024-2037, By
      1. Type, Value (USD Million)
        1. Synthetic Pericardial Patches
        2. Biological Pericardial Patches
          1. Autologous
          2. Xenograft
      2. Source, Value (USD Million)
        1. Bovine
        2. Porcine
        3. Equine
        4. Others
      3. Application, Value (USD Million)
        1. Cardiovascular Surgery
        2. Heart Valve Repair
        3. Congenital Heart Defects
        4. Dental Surgery
        5. Others
      4. End user, Value (USD Million)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Center
        4. Research and Academic Institutes
      5. Country Level Analysis, Value (USD Million)
        1. U.S.
        2. Canada
  7. Europe Market
    1. Overview
      1. Market Value (USD Million), Current and Future Projections, 2024-2037
      2. Increment $ Opportunity Assessment, 2024-2037
      3. Year-on-Year Growth Forecast (%)
    2. Segmentation (USD Million), 2024-2037, By
      1. Type, Value (USD Million)
        1. Synthetic Pericardial Patches
        2. Biological Pericardial Patches
          1. Autologous
          2. Xenograft
      2. Source, Value (USD Million)
        1. Bovine
        2. Porcine
        3. Equine
        4. Others
      3. Application, Value (USD Million)
        1. Cardiovascular Surgery
        2. Heart Valve Repair
        3. Congenital Heart Defects
        4. Dental Surgery
        5. Others
      4. End user, Value (USD Million)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Center
        4. Research and Academic Institutes
      5. Country Level Analysis, Value (USD Million)
        1. UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. NORDIC
        7. Russia
        8. Rest of Europe
  8. Asia Pacific Market
    1. Overview
      1. Market Value (USD Million), Current and Future Projections, 2024-2037
      2. Increment $ Opportunity Assessment, 2024-2037
      3. Year-on-Year Growth Forecast (%)
    2. Segmentation (USD Million), 2024-2037, By
      1. Type, Value (USD Million)
        1. Synthetic Pericardial Patches
        2. Biological Pericardial Patches
          1. Autologous
          2. Xenograft
      2. Source, Value (USD Million)
        1. Bovine
        2. Porcine
        3. Equine
        4. Others
      3. Application, Value (USD Million)
        1. Cardiovascular Surgery
        2. Heart Valve Repair
        3. Congenital Heart Defects
        4. Dental Surgery
        5. Others
      4. End user, Value (USD Million)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Center
        4. Research and Academic Institutes
      5. Country Level Analysis, Value (USD Million)
        1. China
          1. Hong Kong
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Vietnam
        7. Thailand
        8. Singapore
        9. Malaysia
        10. Rest of Asia Pacific
  9. Latin America Market
    1. Global Overview
      1. Market Value (USD Million), Current and Future Projections, 2024-2037
      2. Increment $ Opportunity Assessment, 2024-2037
      3. Year-on-Year Growth Forecast (%)
    2. Global Segmentation (USD Million), By
      1. Type, Value (USD Million)
        1. Synthetic Pericardial Patches
        2. Biological Pericardial Patches
          1. Autologous
          2. Xenograft
      2. Source, Value (USD Million)
        1. Bovine
        2. Porcine
        3. Equine
        4. Others
      3. Application, Value (USD Million)
        1. Cardiovascular Surgery
        2. Heart Valve Repair
        3. Congenital Heart Defects
        4. Dental Surgery
        5. Others
      4. End user, Value (USD Million)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Center
        4. Research and Academic Institutes
      5. Country Level Analysis, Value (USD Million)
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  10. Middle East & Africa Market
    1. Global Overview
      1. Market Value (USD Million), Current and Future Projections, 2024-2037
      2. Increment $ Opportunity Assessment, 2024-2037
      3. Year-on-Year Growth Forecast (%)
    2. Global Segmentation (USD Million), By
      1. Type, Value (USD Million)
        1. Synthetic Pericardial Patches
        2. Biological Pericardial Patches
          1. Autologous
          2. Xenograft
      2. Source, Value (USD Million)
        1. Bovine
        2. Porcine
        3. Equine
        4. Others
      3. Application, Value (USD Million)
        1. Cardiovascular Surgery
        2. Heart Valve Repair
        3. Congenital Heart Defects
        4. Dental Surgery
        5. Others
      4. End user, Value (USD Million)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Center
        4. Research and Academic Institutes
      5. Country Level Analysis, Value (USD Million)
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
  11. Global Economic Scenario
    1. World Economic Outlook
  12. About Research Nester
    1. Our Global Clientele
    2. We Serve Clients Across World

Companies Dominating the Pericardial Patches Landscape

    The pericardial patches market is highly competitive and consists of leading players such as Abbott Laboratories, Baxter International, Collagen Solutions LLC, Edwards Lifesciences Corporation, and LeMaitre Vascular, Inc. These companies are investing heavily in research and development to develop next-generation products for emerging needs in surgery. Strategic partnerships and acquisitions are further enhancing their market reach and strengthening their global presence. This is clearly seen within the focus of their product pipelines, aiming to address the complexities in cardiovascular repairs. These companies continue leveraging the latest technology and clinical expertise to compete. When interacting with each other, these aspects make the pericardial patches market environment dynamic and geared toward growth.

    In January 2024, Neovasc announced positive results from its pivotal trial of the Tiara bioengineered patch. The Tiara patch, designed for precise bioengineering, represents a breakthrough in tackling complex cardiac conditions. This is a sign that the companies in the industry are committed to innovation and underlines the focus of the entire industry on meeting critical needs in cardiovascular care. These results pave the way for potential regulatory approval, reflecting the competitive drive to bring advanced solutions to the market. Furthermore, such developments illustrate the high stakes and rapid pace of innovation characterizing the pericardial patches industry.

    Here are some leading companies in the pericardial patches market

    • ARTIVION, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Abbott Laboratories 
    • Baxter International. 
    • Collagen Solutions LLC 
    • Edwards Lifesciences Corporation 
    • FOC Medical S.A. 
    • Labcor Laboratórios Ltd   
    • LeMaitre Vascular, Inc. 
    • Visionary Medtech Solutions Pvt. Ltd. 
    • W. L. Gore & Associates, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • In February 2024, Terumo Medical Corporation partnered with InHeart Pharma to develop a bioresorbable patch for atrial fibrillation, aiming to advance minimally invasive treatments for this condition, which is closely linked to increased stroke risk. This collaboration underscores Terumo’s dedication to delivering innovative solutions in cardiac care.
  • In December 2023, TEI Biosciences Inc. received FDA 510(k) clearance for its DermaMatrix Advanced Wound Care Patch, designed to treat diabetic foot ulcers, thereby expanding their product portfolio and addressing a significant unmet need in wound care. This approval further cements TEI’s leadership in regenerative wound treatment.
  • In October 2023, LeMaitre Vascular formed a strategic partnership with Aziyo Biologics to distribute Aziyo's cardiovascular and soft tissue repair products, enhancing LeMaitre's product offerings and bolstering its position in the market. This alliance combines both companies’ strengths to improve surgical outcomes.

Author Credits:  Radhika Pawar


  • Report ID: 4589
  • Published Date: Nov 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In 2024, the industry size of pericardial patches was USD 336.8 million.

The global pericardial patches market size was USD 336.8 million in 2024 and is expected to reach USD 777.9 million by the end of 2037, expanding at a CAGR of 6.6% during the forecast period, i.e., 2025-2037. In 2025, the industry size of pericardial patches will be valued at USD 358.8 million.

Key players in the market are Abbott Laboratories, Baxter International., Collagen Solutions (US) LLC, Edwards Lifesciences Corporation, FOC Medical S.A., Labcor Laboratórios Ltd, LeMaitre Vascular, Inc., Visionary Medtech Solutions Pvt. Ltd., and W. L. Gore & Associates, Inc.

The biological pericardial patches segment is predicted to lead the market during the forecast period.

Asia Pacific is anticipated to become a lucrative market for companies in the pericardial patches market during the forecast period.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample